EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GALNT1 emerges as a potential therapeutic target in breast cancer

Jiafu Li, Pei Zhong, Xizhuang Li, Rongzhi Huang, Zexu Zhan, Jiehua Li, Min Mao

Journal of Cancer Research and Clinical Oncology · 25.03.2026 · 152 (3)

DOI: 10.1007/s00432-026-06448-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 25.03.2026. Verfasst von Jiafu Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal and Gland Surgery, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang-Yong Road, Nanning, 530021, T…. Hauptthemen laut MEDLINE: N-Acetylgalactosaminyltransferases, Breast Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovation Project of Guangxi Graduate Education, Youth Science Foundation of Guangxi Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-AcetylgalactosaminyltransferasesBreast NeoplasmsHumansFemalePolypeptide N-acetylgalactosaminyltransferaseCell ProliferationGlycosylationTumor MicroenvironmentCell MovementGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

Breast cancerDrug resistanceGALNT1Single-cell transcriptomicsTumor microenvironment

Substanzen

N-AcetylgalactosaminyltransferasesPolypeptide N-acetylgalactosaminyltransferase

Autor:innen und Institutionen

  • Department of Gastrointestinal and Gland Surgery, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang-Yong Road, Nanning, 530021, The Guangxi Zhuang Autonomous Region, China.
  • Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
  • Department of Gastrointestinal and Gland Surgery, The First Affiliated Hospital of Guangxi Medical University, 6 Shuang-Yong Road, Nanning, 530021, The Guangxi Zhuang Autonomous Region, China. lijiehua01@sina.com.
  • Department of Thyroid and Breast Surgery, The First People's Hospital of Qinzhou, Qinzhou, 535000, Guangxi, China. min15289679719@163.com.

Förderung

  • Innovation Project of Guangxi Graduate Education
  • Youth Science Foundation of Guangxi Medical University

Zitieren

APA

Li, J., Zhong, P., Li, X., Huang, R., Zhan, Z., Li, J., & Mao, M. (2026). GALNT1 emerges as a potential therapeutic target in breast cancer. Journal of Cancer Research and Clinical Oncology, 152(3). https://doi.org/10.1007/s00432-026-06448-2

Vancouver

Li J, Zhong P, Li X, Huang R, Zhan Z, Li J, et al. GALNT1 emerges as a potential therapeutic target in breast cancer. Journal of Cancer Research and Clinical Oncology. 2026;152(3). doi:10.1007/s00432-026-06448-2

BibTeX
@article{Li2026,
  author = {Li, Jiafu and Zhong, Pei and Li, Xizhuang and Huang, Rongzhi and Zhan, Zexu and Li, Jiehua and Mao, Min},
  title = {GALNT1 emerges as a potential therapeutic target in breast cancer},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2026},
  volume = {152},
  number = {3},
  doi = {10.1007/s00432-026-06448-2}
}
Kostenlos starten →